Genetic Testing For Color Vision Makes Commercial Debut for Military Applications
By Dan Buckland,
medGadget
| 06. 12. 2012
Possibly heralding a new era in the use of genetic testing for hiring decisions,
Genevolve (Albuquerque, NM) announced at the recent Aerospace Medicine Association conference in Atlanta, GA a new “military grade” test for inherited color blindness. A few years ago we
posted on research done at the Neitz lab at the University of Washington that used gene therapy to cure color blindness in monkeys. Aspects of that research were used to produce the technology Genevolve uses for its test, called Eyedox. Eyedox uses a buccal swab that is sent to the company, which analyzes the sample for color genes (likely the ones detailed in this review
paper by Neitz) and returns the type of deficiency and severity on a scale of 1-100, 100 being normal.
A press release from the company details what they envision the test could be used for:
“This prevents a qualified applicant from being denied entry into a field they can adequately perform and eliminates cheating or administrator bias that may allow some severely colorblinds to slip through the system,” says [President of Genevolve]...
Related Articles
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...
By Alexandra Marquez, NBC News | 03.13.2026
“Donald Trump” by Gage Skidmore is licensed under CC BY-SA 2.0
President Donald Trump on Thursday blamed “the genetics” of assailants in a string of recent attacks across the country. He made the comments after attacks at a...